960492-59-5 Usage
Description
3-Chloro-6-(5-methyl-1,3,4-oxadiazol-2-yl)pyridazine is a chemical compound that belongs to the pyridazine family. It is characterized by a chloro group on the 3rd position and a 6-membered ring containing a 1,3,4-oxadiazole moiety on the 6th position of the pyridazine ring. This unique structure, along with its functional groups, makes it a promising candidate for further research and development in the synthesis of novel pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
3-Chloro-6-(5-methyl-1,3,4-oxadiazol-2-yl)pyridazine is used as a building block for the synthesis of new pharmaceutical compounds. Its structural attributes and functional groups contribute to the development of potential drugs with therapeutic properties.
Used in Agrochemical Industry:
3-Chloro-6-(5-methyl-1,3,4-oxadiazol-2-yl)pyridazine is used as a key intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its unique structure and functional groups enable the creation of effective and targeted agrochemicals for crop protection and management.
Check Digit Verification of cas no
The CAS Registry Mumber 960492-59-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,6,0,4,9 and 2 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 960492-59:
(8*9)+(7*6)+(6*0)+(5*4)+(4*9)+(3*2)+(2*5)+(1*9)=195
195 % 10 = 5
So 960492-59-5 is a valid CAS Registry Number.
960492-59-5Relevant articles and documents
Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors
Isabel, Elise,Powell, David A.,Black, W. Cameron,Chan, Chi-Chung,Crane, Sheldon,Gordon, Robert,Guay, Jocelyne,Guiral, Sebastien,Huang, Zheng,Robichaud, Jo?l,Skorey, Kathryn,Tawa, Paul,Xu, Lijing,Zhang, Lei,Oballa, Renata
scheme or table, p. 479 - 483 (2011/02/28)
Potent and orally bioavailable SCD inhibitors built on an azetidinyl pyridazine scaffold were identified. In a one-month gDIO mouse model of obesity, we demonstrated that there was no therapeutic index even at low doses; efficacy in preventing weight gain
